Prevymis (letermovir) - Merck (MSD)
Closed-loop integration of life cycle assessment in complex molecule synthesis: Case study antiviral Letermovir | Poster Board #1200 (ACS-Fall 2026) - Aug 24, 2026 - Abstract #4527150; Pres time: Aug 25, 2026; 01:00 PM - 03:00 PM; Location: Hall F2 - POSTERS (McCormick Place Convention Center); "Across both routes, key environmental contributions are traced to asymmetric catalysis and metal-mediated coupling steps, identifying critical leverage points for sustainability improvement. Overall, this work demonstrates how embedding LCA into synthetic design complements classical green chemistry metrics and supports informed, sustainability-driven decision-making in complex multistep synthesis." 
Case study • Clinical
https://acs.digitellinc.com/live/37/session/588014
 
Sander Folkerts; Erick Carreira; Javier Perez-Ramirez; Gonzalo Guillén-Gosálbez; Maximilian Hoepfner
 
Aug 24, 2026
 
Prev Next